Why Sentara Health Invested $11M Into iPhones for Nurses 

Sentara Health invested $11 million into smartphones for its nurses, equipping them with HIPAA-compliant devices to streamline communication, increase time at the bedside and improve patient outcomes. The program has been going on for a little more than a year — and Amy Rosa, the health system’s chief nursing informatics officer, says the initiative is…

Read More

What a US Exit From the WHO Means for Global Health

For decades, the United States has held considerable power in determining the direction of global health policies and programs. President Donald Trump issued three executive orders on his first day in office that may signal the end of that era, health policy experts said. Trump’s order to withdraw from the World Health Organization means the…

Read More

Medicaid Section 1115 Waivers: The Basics

Section 1115 Medicaid demonstration waivers offer states an avenue to test new approaches in Medicaid that differ from what is required by federal statute. Nearly all states have at least one active Section 1115 waiver and some states have multiple 1115 waivers. This brief explains what Section 1115 waivers are and how they are used,…

Read More

Peter Yellowlees, Asynch Health

Peter Yellowlees MD is CEO at Asynch Health–this is a new company that is doing the intake interview for a psychiatrist or psychologist session. Peter demos how the AI agent asks questions, how a patient answers in real time. Then after submitting the answers, the AI creates both a full transcript in the back end,…

Read More

Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More

Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said. The post Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More…

Read More